STSS
Sharps Technology, Inc.NASDAQHealthcare$1.51-7.36%ClosedMarket Cap: $43.8M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
0.14
P/S
17.93
EV/EBITDA
-0.13
DCF Value
$0.39
FCF Yield
-25.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
57.1%
Operating Margin
-11194.5%
Net Margin
-11724.3%
ROE
-156.5%
ROA
-105.0%
ROIC
-2779.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $-2.3M | 0.0% | $-154.1M | $-182.7M | $-49.03 | — |
| FY 2025 | $204.1K | -202.5% | $-269.7M | $-282.5M | $-11.16 | — |
| Q3 2025 | $2.3M | 38.9% | $-110.6M | $-105.3M | $-4.33 | — |
| Q2 2025 | $222.7K | -526.4% | $-3.0M | $3.6M | $3.58 | — |
| Q1 2025 | $0.00 | -Infinity% | $-2.0M | $1.9M | $38.62 | — |
| Q4 2024 | $0.00 | -Infinity% | $-2.1M | $-4.5M | $-662.99 | — |
| FY 2024 | $0.00 | -Infinity% | $-7.9M | $-9.3M | $-2,220.05 | — |
| Q3 2024 | $0.00 | -Infinity% | $-2.0M | $-1.7M | $-379.57 | — |
| Q2 2024 | $0.00 | -Infinity% | $-1.9M | $-2.1M | $-643.63 | — |
| Q1 2024 | $0.00 | -Infinity% | $-1.8M | $-982.4K | $-347.56 | — |
| Q4 2023 | $0.00 | -Infinity% | $-2.9M | $-3.1M | $-1,340.20 | — |
| FY 2023 | $0.00 | -Infinity% | $-10.1M | $-9.8M | $-4,983.99 | — |